Ventricular fibrillation after bortezomib therapy in a patient with systemic amyloidosis.
about
Recurrent Syncope and Cardiac Arrest in a Patient with Systemic Light Chain Amyloidosis Treated with Bortezomib.Changes in cardiac biomarkers with bortezomib treatment in patients with advanced cardiac amyloidosisScreening for arteriovenous malformations in hereditary haemorrhagic telangiectasia.Rationale and design of DUAL study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosis
P2860
Ventricular fibrillation after bortezomib therapy in a patient with systemic amyloidosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ventricular fibrillation after bortezomib therapy in a patient with systemic amyloidosis.
@en
Ventricular fibrillation after bortezomib therapy in a patient with systemic amyloidosis.
@nl
type
label
Ventricular fibrillation after bortezomib therapy in a patient with systemic amyloidosis.
@en
Ventricular fibrillation after bortezomib therapy in a patient with systemic amyloidosis.
@nl
prefLabel
Ventricular fibrillation after bortezomib therapy in a patient with systemic amyloidosis.
@en
Ventricular fibrillation after bortezomib therapy in a patient with systemic amyloidosis.
@nl
P2093
P2860
P356
P1433
P1476
Ventricular fibrillation after bortezomib therapy in a patient with systemic amyloidosis.
@en
P2093
Eiko Zaitsu
Hirotake Kusumoto
Koichi Akashi
Satoshi Yamasaki
Taiki Higo
Toshihiro Miyamoto
Tsuyoshi Muta
Yoshinao Oda
P2860
P356
10.4081/HR.2013.E12
P577
2013-09-16T00:00:00Z